• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Dr. Sandrine Garnier takes office as CEO of Polygiene Group and Niklas Blomstedt has been appointed as Deputy CEO

POLYGSelskabsmeddelelse18.12.2025, 13.00
Download udgivelse

Polygiene Group AB (publ.) (“Polygiene Group” or the “Company”) announces that Dr. Sandrine Garnier assumes her role as Chief Executive Officer today, and that the Board of Directors has appointed the Company’s CFO, Niklas Blomstedt, as Deputy Chief Executive Officer.

As the Company announced in a press release on 26 November 2025, Dr. Sandrine Garnier has been appointed as the new Chief Executive Officer of Polygiene Group. Today, she assumes the position, succeeding outgoing CEO Ulrika Björk after eight years in the role. In connection with Dr. Garnier’s assumption of office, the Board of Directors has today also resolved to appoint the Company’s CFO, Niklas Blomstedt, as Deputy Chief Executive Officer, with effect from today's date. Niklas Blomstedt has worked at Polygiene Group since 2022 and will also remain in his role as CFO.

For more information, please contact:
Jonas Wollin, Chairman of the Board
Phone: +46 (0) 706- 34 09 86
Email: jonas.wollin@rudholmgroup.com

About Us
Polygiene Group is a global leader in ingredient technologies designed to enhance freshness and performance across products and materials. Through its Polygiene and Addmaster companies, the Group partners with over 500 leading brands worldwide to deliver advanced solutions that add lasting value.
 
With technologies such as StayFresh, StayCool, OdorCrunch, Scentmaster, Biomaster, and Verimaster, Polygiene Group combines innovation with industry expertise to strengthen product performance and differentiation. Headquartered in Sweden, Polygiene Group is listed on the Nasdaq First North Growth Market in Stockholm.
 
Svensk Kapitalmarknadsgranskning AB is the Company's Certified Adviser.

Attachments
Dr. Sandrine Garnier takes office as CEO of Polygiene Group and Niklas Blomstedt has been appointed as Deputy CEO